Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Pharmacotherapy of behavioral and psychological symptoms of dementia: Timefor a different paradigm?
Autore:
Rojas-Fernandez, CH; Lanctot, KL; Allen, DD; MacKnight, C;
Indirizzi:
Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Practice, Amarillo, TX 79106 USA Texas Tech Univ Amarillo TX USA 79106 rm Practice, Amarillo, TX 79106 USA Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX 79106 USA Texas Tech Univ Amarillo TX USA 79106 rmaceut Sci, Amarillo, TX 79106 USA Univ Toronto, Div Clin Pharmacol & Psychiat, Toronto, ON, Canada Univ Toronto Toronto ON Canada Pharmacol & Psychiat, Toronto, ON, Canada Dalhousie Univ, Div Geriatr Med, Halifax, NS, Canada Dalhousie Univ Halifax NS Canada v, Div Geriatr Med, Halifax, NS, Canada
Titolo Testata:
PHARMACOTHERAPY
fascicolo: 1, volume: 21, anno: 2001,
pagine: 74 - 102
SICI:
0277-0008(200101)21:1<74:POBAPS>2.0.ZU;2-H
Fonte:
ISI
Lingua:
ENG
Soggetto:
SEROTONIN REUPTAKE INHIBITORS; NURSING-HOME RESIDENTS; CEREBRAL BLOOD-FLOW; INTERMITTENT EXPLOSIVE DISORDER; ADVANCED PARKINSONS-DISEASE; LEWY BODY DEMENTIA; DOUBLE-BLIND TRIAL; ALZHEIMERS-DISEASE; AGGRESSIVE-BEHAVIOR; PSYCHIATRIC-SYMPTOMS;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
289
Recensione:
Indirizzi per estratti:
Indirizzo: Rojas-Fernandez, CH Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Practice, 1300 Coulter, Amarillo, TX 79106 USA Texas Tech Univ 1300 Coulter Amarillo TX USA 79106 USA
Citazione:
C.H. Rojas-Fernandez et al., "Pharmacotherapy of behavioral and psychological symptoms of dementia: Timefor a different paradigm?", PHARMACOTHE, 21(1), 2001, pp. 74-102

Abstract

Behavioral and psychological symptoms of dementia can occur in 60-80% of patients with Alzheimer's disease or other dementing illnesses, and are important in that they are a source of significant caregiver stress and often precipitate nursing home placement. These symptoms, namely, aggression, delusions, hallucinations, apathy, anxiety, and depression, are clinically managed with a variety of psychotropic drugs such as antipsychotics, antidepressants, antiepileptic drugs, and benzodiazepines. Various advances in the neuropathophysiology and pharmacotherapy must be considered in the optimal design of regimens for patients with these symptoms.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/20 alle ore 07:51:16